KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $419,033 | +23.6% | 24,124 | +0.2% | 0.00% | – |
| Q2 2023 | $338,890 | +153.5% | 24,069 | +93.7% | 0.00% | – |
| Q1 2023 | $133,693 | -23.8% | 12,425 | +6.1% | 0.00% | – |
| Q4 2022 | $175,445 | +26.2% | 11,712 | +7.8% | 0.00% | – |
| Q3 2022 | $139,000 | +35.0% | 10,862 | +1.4% | 0.00% | – |
| Q2 2022 | $103,000 | +21.2% | 10,714 | +25.3% | 0.00% | – |
| Q1 2022 | $85,000 | -15.8% | 8,552 | 0.0% | 0.00% | – |
| Q4 2021 | $101,000 | +4.1% | 8,552 | 0.0% | 0.00% | – |
| Q3 2021 | $97,000 | +83.0% | 8,552 | +123.9% | 0.00% | – |
| Q2 2021 | $53,000 | -35.4% | 3,820 | -13.6% | 0.00% | – |
| Q1 2021 | $82,000 | +7.9% | 4,421 | +3.0% | 0.00% | – |
| Q4 2020 | $76,000 | +15.2% | 4,291 | 0.0% | 0.00% | – |
| Q3 2020 | $66,000 | -38.9% | 4,291 | +0.7% | 0.00% | – |
| Q2 2020 | $108,000 | +272.4% | 4,262 | +87.2% | 0.00% | – |
| Q1 2020 | $29,000 | -14.7% | 2,277 | -26.4% | 0.00% | – |
| Q4 2019 | $34,000 | +54.5% | 3,092 | +21.0% | 0.00% | – |
| Q3 2019 | $22,000 | -37.1% | 2,555 | 0.0% | 0.00% | – |
| Q2 2019 | $35,000 | -2.8% | 2,555 | +28.4% | 0.00% | – |
| Q1 2019 | $36,000 | +28.6% | 1,990 | +103.1% | 0.00% | – |
| Q4 2018 | $28,000 | +12.0% | 980 | 0.0% | 0.00% | – |
| Q3 2018 | $25,000 | – | 980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |